Exploiting MEK Inhibitor-Mediated Activation of ERα for Therapeutic Intervention in ER-Positive Ovarian Carcinoma

Serine-305 Phosphorylation Modulates Estrogen Receptor Alpha Binding to a Coregulator Peptide Array, with Potential Application in Predicting Responses to Tamoxifen

(2012) R. Houtman et al.   MOLECULAR CANCER THERAPEUTICS

Deficiency in trefoil factor 1 (TFF1) increases tumorigenicity of human breast cancer cells and mammary tumor development in TFF1-knockout mice

(2011) E Buache et al.   ONCOGENE

Phase II study of fulvestrant in recurrent/metastatic endometrial carcinoma: A Gynecologic Oncology Group Study

(2010) Allan L. Covens et al.   GYNECOLOGIC ONCOLOGY

Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma

(2010) Gideon Bollag et al.   NATURE

Molecular Characterization of 103 Ovarian Serous and Mucinous Tumors

(2010) Ildikó Vereczkey et al.   PATHOLOGY & ONCOLOGY RESEARCH

Precursor Lesions of High-Grade Serous Ovarian Carcinoma: Morphological and Molecular Characteristics

(2010) Amy L. Gross et al.   Journal of Oncology

Defining the Cut Point Between Low-grade and High-grade Ovarian Serous Carcinomas

(2009) Ayse Ayhan et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

mTOR/S6K1 and MAPK/RSK signaling pathways coordinately regulate estrogen receptor α serine 167 phosphorylation

(2009) Rachel L. Yamnik et al.   FEBS LETTERS

Estrogen and progesterone receptor status and outcome in epithelial ovarian cancers and low malignant potential tumors

(2009) Hugo Arias-Pulido et al.   GYNECOLOGIC ONCOLOGY

A phase II study of fulvestrant in the treatment of multiply-recurrent epithelial ovarian cancer

(2009) Peter A. Argenta et al.   GYNECOLOGIC ONCOLOGY

Estrogen utilization of IGF-1-R and EGF-R to signal in breast cancer cells

(2009) Robert X.-D. Song et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Combination of EGFR and MEK1/2 inhibitor shows synergistic effects by suppressing EGFR/HER3-dependent AKT activation in human gastric cancer cells

(2009) Y.-K. Yoon et al.   MOLECULAR CANCER THERAPEUTICS

Investigating Differential Dynamics of the MAPK Signaling Cascade Using a Multi-Parametric Global Sensitivity Analysis

(2009) Jeongah Yoon et al.   PLoS One

Amplification and invasiveness of epithelial progenitors during gastric carcinogenesis in trefoil factor 1 knockout mice

(2008) S. M. Karam et al.   CELL PROLIFERATION

Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum

(2008) Kathleen M. Schmeler et al.   GYNECOLOGIC ONCOLOGY

Systematic Mapping of Posttranslational Modifications in Human Estrogen Receptor-α with Emphasis on Novel Phosphorylation Sites

(2008) Christian Atsriku et al.   MOLECULAR & CELLULAR PROTEOMICS